4071 - 4080 of 7915 Results
Title
Year
-
OPENTitle: Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 95Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000009952Best OA location URL: https://n.neurology.org/content/neurology/95/4/e436.full.pdfCitation Count: 0
- Pharmacotherapy Use for Non-Motor Symptoms Among de novo Parkinson’s Disease Parkinson’s Progression Markers Initiative Participants2020OPENTitle: Pharmacotherapy Use for Non-Motor Symptoms Among de novo Parkinson’s Disease Parkinson’s Progression Markers Initiative ParticipantsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 3Start Page: 1239End Page: 1243Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-201973Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415719Citation Count: 2
- Plasma Metabolomic Markers of Insulin Resistance and Diabetes and Rate of Incident Parkinson’s Disease2020OPENTitle: Plasma Metabolomic Markers of Insulin Resistance and Diabetes and Rate of Incident Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 3Start Page: 1011End Page: 1021Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-191896Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034435Citation Count: 8
- Recommendations for the Organization of Multidisciplinary Clinical Care Teams in Parkinson’s Disease2020OPENTitle: Recommendations for the Organization of Multidisciplinary Clinical Care Teams in Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 3Start Page: 1087End Page: 1098Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-202078Best OA location URL: https://repository.ubn.ru.nl//bitstream/handle/2066/221564/221564.pdfCitation Count: 64
-
RESTRICTEDTitle: Aspirin and ibuprofen could lower risk of LRRK2 Parkinson diseaseJournal Name: Nature Reviews NeurologyPublisher: Springer Science and Business Media LLCVol: 16Issue #: 9Start Page: 460End Page: 460Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41582-020-0394-7Best OA location URL: https://www.nature.com/articles/s41582-020-0394-7.pdfCitation Count: 12
-
RESTRICTEDTitle: Low cerebrospinal fluid volume and the risk for post-lumbar puncture headachesJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 417Issue #:Start Page: 117059End Page: 117059Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2020.117059Citation Count: 4
- Quantitative ultrasound radiomics for therapy response monitoring in patients with locally advanced breast cancer: Multi-institutional study results2020OPENTitle: Quantitative ultrasound radiomics for therapy response monitoring in patients with locally advanced breast cancer: Multi-institutional study resultsJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 15Issue #: 7Start Page: e0236182End Page: e0236182Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1371/journal.pone.0236182Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0236182&type=printableCitation Count: 37
- A Parkinson's disease Circ RNA s Resource reveals a link between circ SLC 8A1 and oxidative stress2020OPENTitle: A Parkinson's disease Circ RNA s Resource reveals a link between circ SLC 8A1 and oxidative stressJournal Name: EMBO Molecular MedicinePublisher: Springer Science and Business Media LLCVol: 12Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.15252/emmm.201911942Best OA location URL: https://doi.org/10.15252/emmm.201911942Citation Count: 99
- Precision Neurology for Parkinson’s Disease: Coupling Miro1‐Based Diagnosis With Drug Discovery2020OPENTitle: Precision Neurology for Parkinson’s Disease: Coupling Miro1‐Based Diagnosis With Drug DiscoveryJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 9Start Page: 1502End Page: 1508Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific, author manuscriptDOI - Digital Object Identifier: 10.1002/mds.28194Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28194Citation Count: 10
- Tryptophan Metabolites Are Associated With Symptoms and Nigral Pathology in Parkinson's Disease2020OPENTitle: Tryptophan Metabolites Are Associated With Symptoms and Nigral Pathology in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 11Start Page: 2028End Page: 2037Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28202Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28202Citation Count: 69